Difference between revisions of "Coagulopathy (main)"
Neil.m.young (talk | contribs) |
(→Managment) |
||
| Line 10: | Line 10: | ||
**[[Warfarin (Coumadin) Reversal]] | **[[Warfarin (Coumadin) Reversal]] | ||
**[[Dabigatran (Pradaxa) Reversal]] | **[[Dabigatran (Pradaxa) Reversal]] | ||
| + | *[[Rivaroxaban reversal]] | ||
**[[Unfractionated heparin reversal]] | **[[Unfractionated heparin reversal]] | ||
Revision as of 08:40, 12 January 2016
Contents
Differential Diagnosis
Coagulopathy
Platelet Related
- Too few
- Nonfunctional
Factor Related
- Acquired (Drug Related)
- Warfarin (Coumadin)
- Unfractionated heparin
- Low molecular weight heparin (i.e. enoxaparin (Lovenox), dalteparin)
- Factor Xa Inhibitors (e.g. rivaroxaban, apixaban, fondaparinux, edoxaban)
- Direct thrombin inhibitors (e.g. dabigatran, argatroban, bivalirudin)
- Illness induced
- Genetic
Increased Clotting
Managment
- Bleeding Treatments
- Procedures in patients with coagulopathies
- Reversing known medications
- Rivaroxaban reversal